ICTR in the News: Johns Hopkins inHealth Hosts Event About the Challenges Surrounding the Future of Immunotherapy and Precision Medicine

The following article profiles an event that will feature contributions from ICTR researchers Elizabeth Jaffee, M.D., Associate Director, Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy Deputy Director, Johns Hopkins Kimmel Cancer Center and William Nelson, M.D., Ph.D., Director, Johns Hopkins Kimmel Cancer Center.

Johns Hopkins inHealth, an initiative of Johns Hopkins aimed at moving the field of individualized health forward, will kick off a brand-new event series called On the Road to Precision Medicine Health Care Leader Series. The series will address some of the challenges and obstacles faced in the field of precision medicine. The inaugural event taking place

inhealth

Credit: Johns Hopkins Medicine

March 8 at the National Press Club will focus on the future of immunotherapy. Leading experts will gather to discuss topics such as cost, communication, research and health care delivery

What:
“Immunotherapy: Precision Medicine in Action”
An expert panel will provide insight about the obstacles immunotherapy is facing today.

When:
Wednesday, March 8, 2017
9–10:30 a.m.

Where:
National Press Club
529 14th St. NW
13th Floor, Fourth Estate Room
Washington, DC 20045

Who:

Margaret Anderson
Executive Director, FasterCures

Roy Baynes, M.D., Ph.D.
Senior Vice President, Clinical Development and Chief Medical Officer, Merck Research Laboratories

Glenn Dranoff, M.D.
Global Head of Exploratory Immuno-Oncology, Novartis

Elizabeth Jaffee, M.D.
Associate Director, Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy
Deputy Director, Johns Hopkins Kimmel Cancer Center

William Nelson, M.D., Ph.D.
Director, Johns Hopkins Kimmel Cancer Center

FOR THE MEDIA

Contacts:

410-502-9429
mhedin2@jhmi.edu

410-502-9468
anilawe1@jhmi.edu

Source: http://www.hopkinsmedicine.org/news/media/releases/media_alert_johns_hopkins_inhealth_hosts_event_about_the_challenges_surrounding_the_future_of_immunotherapy_and_precision_medicine_